tirzepatide max dose for weight loss Dosing Microdosing Tirzepatide Chart: A Weekly

Take charge of your spring weight loss goals

Tirzepatide (LY3298176) is a 39-amino acid synthetic peptide and the first approved dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors

That $149 isn't Walgreens' price

Long-term adherence is essential to realizing the full therapeutic potential of GLP-1s, yet behavioral factors (such as reaching personal weight goals or perceived social stigma) and systemic issues (like high out-of-pocket costs and fragmented care) disproportionately affect obesity patients

Through our technology, were making high-quality care more affordable, more accessible, and easier to get started.